Welcome to our dedicated page for Orix SEC filings (Ticker: IX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ORIX Corporation (IX) filings document the disclosures of a foreign private issuer with American depositary shares listed on the NYSE. Its Form 20-F annual reports and Form 6-K current reports cover consolidated operating and financial results, U.S. GAAP reporting, audited financial statements, dividends, share repurchases, and the capital structure of the Japanese parent company.
ORIX's current reports also record governance and corporate-organization matters, including management changes, board and committee composition, amendments to articles of incorporation, and business-unit reforms. Material-event filings describe subsidiary and portfolio actions across banking, private equity, infrastructure, real estate and other financial-services activities, along with extraordinary-report disclosures tied to those corporate events.
Overview: OPI18 Corporation, a subsidiary of ORIX Corporation, conducted a tender offer for Ascentech K.K. (TSE: 3565) from June 17, 2025 to August 4, 2025 at JPY 1,680 per share. The Offeror set a minimum purchase condition of 9,546,000 shares and a maximum of 14,318,978 shares.
Result: A total of 9,259,301 shares were tendered, which did not meet the minimum threshold, and therefore the Offeror will not purchase any Tendered Shares. Public notice of the results was made at the Tokyo Stock Exchange on August 5, 2025. Tendered share records will be reverted on August 6, 2025. Further details are available in the Offeror's separate notice dated August 5, 2025.
ORIX Corporation (NYSE: IX) has entered into a definitive agreement for its U.S. subsidiary, ORIX Corporation USA (OCU), to acquire 71.4% of Hilco Trading, LLC ("Hilco Global") for USD 776 million. Completion is targeted for the end of September 2025, pending Hart-Scott-Rodino and FINRA clearances and other customary conditions.
Strategic rationale: OCU manages USD 89.8 billion in assets and is pivoting toward an asset-management model. Hilco adds world-leading valuation, liquidation and asset-based lending expertise, positioning OCU to originate asset-based loans in a U.S. market that has expanded from USD 400 billion in 2018 to USD 550 billion in 2025, with mid-single-digit growth expected. Hilco will gain access to ORIX capital to broaden financing solutions for its clients.
Hilco financial profile (unaudited):
- 2024 revenue USD 326.3 million, up 29% versus 2022.
- 2024 net income USD 53.1 million.
- Capital USD 307.5 million; total assets USD 612.4 million.
Transaction details:
- Equity purchased: 71.4 units (71.4% voting rights).
- Purchase price: USD 776 million (~2.5× 2024 revenue, ~14.6× 2024 net income).
- Acquisition via a new wholly-owned vehicle under OCU.
Impact guidance: ORIX states the effect on consolidated FY 2025/26 earnings will be "immaterial"; however, the deal advances its U.S. alternative-asset franchise and fee-based income diversification.
ORIX (NYSE:IX) filed a routine Form 6-K reporting the official results of its 62nd Annual General Meeting of Shareholders held on 25 June 2025.
All 11 director nominees – nine incumbents and two first-time candidates – were elected with overwhelming support. Approval rates ranged from 97.24 % to 99.78 %; the highest support went to new nominee Miwa Seki (99.78 %). The company explains that a portion of on-site votes was not tallied because each proposal had already secured the required majority through advance proxy submissions.
No other agenda items, financial results, strategic changes, or risk disclosures were included in the filing, making the submission primarily an administrative confirmation of shareholder voting outcomes.
ORIX (NYSE:IX) submitted a Form 6-K furnishing an English translation of the corporate governance report it filed with the Tokyo Stock Exchange on 27 June 2025.
The report confirms that ORIX complies with every principle of Japan’s Corporate Governance Code, states that the company does not engage in cross-shareholdings of listed equities and details strict internal controls for related-party transactions. Sustainability oversight is conducted by a dedicated committee chaired by the Group CEO, with material matters elevated to the board.
Key human-capital metrics as of 31 March 2025 include: female employees 45.4%, female managers 33.2%, mid-career hires 41.5% and non-Japanese employees 2.0% at the parent company. ORIX’s ESG goal is to keep female representation in management above 30% group-wide by FY-end March 2030. No financial statements, acquisitions or other material transactions were disclosed in this filing.
ORIX (NYSE:IX) filed a Form 6-K disclosing management changes and an organizational reform that take effect on 1 July 2025.
Management changes: Satoru Matsuzaki remains a Member of the Board and will serve as Deputy President Executive Officer, Group Strategy Business Unit, Responsible for Asia-Pacific, while continuing as Chairperson of ORIX Auto and ORIX Rentec. Yoshiaki Matsuoka is promoted to Executive Officer, Group Strategy Business Unit, Responsible for Asia-Pacific Business.
Organizational reform: The current Asia and Australia Business Group will be divided into two standalone units—Asia-Pacific Strategic Planning Department and Asia-Pacific Business Management Department—to separate long-term strategy from day-to-day regional oversight.
The filing contains no financial data, risk factors, or legal proceedings. The update is operational in nature and signals an effort to sharpen focus and execution in the Asia-Pacific region.
ORIX (NYSE:IX) filed its Form 20-F for the fiscal year ended 31 March 2025. The excerpt emphasises fair-value accounting elections, credit quality metrics and leasing activities rather than consolidated income-statement figures.
Life-insurance operations. Equity assets under management for variable annuity and variable life policies declined to ¥132,313 million from ¥161,244 million (-18%). Policy liabilities carried at fair value fell in tandem to ¥136,257 million. Hedging of minimum-guarantee risk was negligible at year-end 2025, with futures and FX contracts showing zero notional value.
Investment portfolio shifts. Investment funds measured at net asset value expanded 39% year-on-year to ¥118,666 million. Subsidiaries that elected the fair-value option on equity-type investments recorded FY2025 gains of ¥1,954 million, while foreign corporate debt securities produced a ¥441 million gain.
Loans held for sale. Unpaid principal declined to ¥98,135 million (FY24: ¥130,554 million) with fair value at ¥97,694 million. The portfolio reported ¥17,098 million of loans 90-plus days past due or in non-accrual status, compared with none in the prior year, signalling emerging credit stress.
Credit reserves. Allowance for off-balance-sheet credit exposure increased to ¥9,766 million from ¥5,116 million, while allowance for AFS debt securities edged up to ¥670 million.
Leasing & asset sales. Gains on dispositions of real-estate operating lease assets surged 52% to ¥31,965 million; gains on non-real-estate operating lease assets rose 37% to ¥44,668 million. Government-subsidised environmental lease receivables stood at ¥32,357 million.
The filing also details exposure to variable-interest entities, tax benefits of ¥3,380 million from NOL utilisation and several fair-value option elections. No material legal proceedings or new risk factors are disclosed in the provided section.